HKGZ-CCHomo sapiens (Human)Cancer cell line

Also known as: HKGZCC

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_E329
SpeciesHomo sapiens (Human)
Tissue SourceLiver[UBERON:UBERON_0002107]

Donor Information

Age76
Age CategoryAdult
SexMale

Disease Information

DiseaseCholangiocarcinoma
LineageBiliary Tract
SubtypeIntrahepatic Cholangiocarcinoma
OncoTree CodeIHCH

DepMap Information

Source TypeAcademic lab
Source IDACH-001852_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleKRASp.Gln61His (c.183A>C)Heterozygous1 of 3 allelesUnknown, PubMed=8426738

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10
D13S317
10,11
D16S539
9,11
D18S51
16
D21S11
30
D3S1358
16
D5S818
9,11
D7S820
8,11
D8S1179
11,14
FGA
22,24
Penta D
13
Penta E
15
TH01
7,10
TPOX
8
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets.

Vazquez F., Getz G., Bardeesy N.M.

bioRxiv 2024:07.04.601970-07.04.601970(2024).

Development and characterization of human primary cholangiocarcinoma cell lines.

Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.

Am. J. Pathol. 192:1200-1217(2022).

Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.

Bardeesy N.M.

Cancer Discov. 6:727-739(2016).

Establishment and characterization of a human cholangiocarcinoma cell line.

Ma S., Hu L., Huang X.-H., Cao L.-Q., Chan K.-W., Wang Q., Guan X.-Y.

Oncol. Rep. 18:1195-1200(2007).